BIB INTRAGASTRIC BALLOON SYSTEM
Report
- Report Number
- 3005099803-2024-00170
- Event Type
- Injury
- Date Received
- January 26, 2024
- Date of Event
- October 23, 2023
- Report Date
- August 23, 2024
- Manufacturer
- APOLLO ENDOSURGERY
- Product Code
- LTI
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
BLOCK H6 MEDICAL DEVICE CODE A1406 CAPTURES THE REPORTABLE EVENT OF HYPERINFLATION. MEDICAL DEVICE CODE A120507 CAPTURES THE REPORTABLE EVENT OF BALLOON DIFFICULT TO REMOVE. IMDRF IMPACT CODE F2202 CAPTURES THE REPORTABLE EVENT OF ADDITIONAL ENDOSCOPIC PROCEDURE. BLOCK A2 PATIENT STARTING WEIGHT:82 KG. PATIENT EVENT WEIGHT: 82 KG. SUMMARY OF INVESTIGATION: A BIB INTRAGASTRIC BALLOON SYSTEM WAS RETURNED TO BOSTON SCIENTIFIC. A VISUAL INSPECTION OF THE BALLOON WAS PERFORMED IT WAS NOTED THAT THERE WAS A LARGE HOLE THAT ROLLED INWARD. ADDITIONALLY, THE BALLOON WAS DISCOLORED DUE MOST LIKELY WITH METHYLENE BLUE. ACCORDING TO THE INSTRUCTIONS FOR USE (IFU) THE IGB IS PLACES IN THE STOMACH AND FILLED WITH STERILE SALINE. THE ALLEGATION OF HYPERINFLATION WAS CONFIRMED, ADDITIONALLY, IN MEDIA ANALYSIS THE PHOTOS PROVIDED BY THE COSTUMER SHOW INFLATION OF THE BALLOON. THE PROBABLE CAUSE HAS BEEN DETERMINED AS KNOW INHERENT RISK OF DEVIE.
PATIENT STARTING WEIGHT:82 KG. PATIENT EVENT WEIGHT: 82 KG.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ORBERA BALLOON WAS IMPLANTED ON (B)(6) 2023, WITH NO COMPLICATIONS. ON (B)(6) 2023, THE PATIENT PRESENTED WITH PAIN. THE PATIENT UNDERWENT AN ENDOSCOPY PROCEDURE ON (B)(6)2023 WHERE IT WAS FOUND THAT THE BALLOON WAS HYPERINFLATED. THE BALLOON WAS EXPLANTED. AFTER PUNCTURING THE BALLOON WITH A NEEDLE, APPROXIMATELY 680ML OF SERUM WAS ASPIRATED WITH METHYLENE BLUE. THE BALLOON WAS SEIZED WITH GRASPER FORCEPS AND REMOVED UNDER CONTINUOUS TRACTION WITH SOME DIFFICULTY. THERE WERE NO REPORTED PATIENT COMPLICATIONS FOLLOWING THE REMOVAL, AND IT WAS REPORTED THAT THE PATIENT IS WELL. NOTE: IT WAS REPORTED THAT METHYLENE BLUE WAS USED WHEN FILLING THE ORBERA BALLOON. HOWEVER, ACCORDING TO THE INSTRUCTIONS FOR USE (IFU) THE IGB IS PLACES IN THE STOMACH AND FILLED WITH STERILE SALINE.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ORBERA BALLOON WAS IMPLANTED ON (B)(6) 2023 WITH NO COMPLICATIONS. ON (B)(6) 2023 THE PATIENT PRESENTED WITH PAIN. THE PATIENT UNDERWENT AN ENDOSCOPY PROCEDURE ON (B)(6) 2023 WHERE IT WAS FOUND THAT THE BALLOON WAS HYPERINFLATED. THE BALLOON WAS EXPLANTED. AFTER PUNCTURING THE BALLOON WITH A NEEDLE, APPROXIMATELY 680ML OF SERUM WAS ASPIRATED WITH METHYLENE BLUE. THE BALLOON WAS SEIZED WITH GRASPER FORCEPS AND REMOVED UNDER CONTINUOUS TRACTION WITH SOME DIFFICULTY. THERE WERE NO REPORTED PATIENT COMPLICATIONS FOLLOWING THE REMOVAL, AND IT WAS REPORTED THAT THE PATIENT IS WELL. NOTE: IT WAS REPORTED THAT METHYLENE BLUE WAS USED WHEN FILLING THE ORBERA BALLOON. HOWEVER, ACCORDING TO THE INSTRUCTIONS FOR USE (IFU) THE IGB IS PLACES IN THE STOMACH AND FILLED WITH STERILE SALINE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1650089 | BIB INTRAGASTRIC BALLOON SYSTEM | IMPLANT, INTRAGASTRIC FOR MORBID OBESITY | LTI | APOLLO ENDOSURGERY | B-40800 | AF05348 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Required Intervention |